Drug Trial Radar · NCT01294644
Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat
Last checked: Nov 19, 2026Latest source record: Jun 12, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
360
Actual
Start
Jan 2011
Primary completion
Feb 2012
Study completion Feb 2012
Sponsor
- Lead sponsor
- Kythera BiopharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Bayer
- First posted
- Feb 11, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Conditions
- Moderate or Severe Submental Fullness
Interventions
Deoxycholic acid injectionDrug
PlaceboDrug
Phosphate buffered saline placebo for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With a Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) 1-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 24 weeks after first dose)
- Percentage of Participants With a Subject Self Rating Scale (SSRS) ResponseTime frame: Baseline and 12 weeks after last treatment (up to 24 weeks after first dose)
Locations
29 sites in 6 countries. Site status is shown where the registry gives one.
Investigational Site
Geel, Belgium
Investigational Site
Genk, Belgium
Investigational Site
Besançon, France
Investigational Site
Nice, France
Investigational Site
Paris, France
Investigational Site
Paris, France
Investigational Site
Rouen, France
Investigational Site
Berlin, Germany
Investigational Site
Berlin, Germany
Investigational Site
Bochum, Germany
Investigational Site
Dresden, Germany
Investigational Site
Dresden, Germany
Investigational Site
Erlangen, Germany
Investigational Site
Freiburg im Breisgau, Germany
Investigational Site
Hamburg, Germany
Investigational Site
Hamburg, Germany
Investigational Site
Kassel, Germany
Investigational Site
Lübeck, Germany
Investigational Site
Mahlow, Germany
Investigational Site
Mönchengladbach, Germany
Investigational Site
Münster, Germany
Investigational Site
Regensburg, Germany
Investigational Site
Recklinghausen, North Rhine-Westphalia, Germany
Investigational Site
Roma, Italy
Investigational Site
Madrid, Spain
Investigational Site
Birmingham, United Kingdom
Investigational Site
Cardiff, United Kingdom
Investigational Site
London, United Kingdom
Investigational Site
Loughborough, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.